Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA.

Neurol Genet. 2019 Jul 9;5(4):e348. doi: 10.1212/NXG.0000000000000348. eCollection 2019 Aug.

2.

Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.

Deck BL, Xie SX, Choi G, Rick J, Siderowf A, Rudovsky S, Chen-Plotkin A, Duda JE, Morley JF, Dahodwala N, Trojanowski JQ, Weintraub D.

Mov Disord Clin Pract. 2019 May 17;6(6):440-445. doi: 10.1002/mdc3.12781. eCollection 2019 Jul.

PMID:
31392244
3.

Systemic therapy for brain metastases.

Rick JW, Shahin M, Chandra A, Dalle Ore C, Yue JK, Nguyen A, Yagnik G, Sagar S, Arfaie S, Aghi MK.

Crit Rev Oncol Hematol. 2019 Jul 22;142:44-50. doi: 10.1016/j.critrevonc.2019.07.012. [Epub ahead of print] Review.

PMID:
31357143
4.

Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.

Chandra A, Young JS, Dalle Ore C, Dayani F, Lau D, Wadhwa H, Rick JW, Nguyen AT, McDermott MW, Berger MS, Aghi MK.

J Neurosurg. 2019 Jun 21:1-11. doi: 10.3171/2019.3.JNS182629. [Epub ahead of print]

PMID:
31226687
5.

Age and sex-mediated differences in six-month outcomes after mild traumatic brain injury in young adults: a TRACK-TBI study.

Yue JK, Levin HS, Suen CG, Morrissey MR, Runyon SJ, Winkler EA, Puffer RC, Deng H, Robinson CK, Rick JW, Phelps RRL, Sharma S, Taylor SR, Vassar MJ, Cnossen MC, Lingsma HF, Gardner RC, Temkin NR, Barber J, Dikmen SS, Yuh EL, Mukherjee P, Stein MB, Cage TA, Valadka AB, Okonkwo DO, Manley GT; TRACK-TBI Investigators.

Neurol Res. 2019 Jul;41(7):609-623. doi: 10.1080/01616412.2019.1602312. Epub 2019 Apr 21.

PMID:
31007155
6.

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.

Tropea TF, Mak J, Guo MH, Xie SX, Suh E, Rick J, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Trojanowski JQ, Van Deerlin V, Chen-Plotkin AS.

Ann Neurol. 2019 Jun;85(6):801-811. doi: 10.1002/ana.25486.

PMID:
30973966
7.

Presence of Histopathological Treatment Effects at Resection of Recurrent Glioblastoma: Incidence and Effect on Outcome.

Dalle Ore CL, Chandra A, Rick J, Lau D, Shahin M, Nguyen AT, McDermott M, Berger MS, Aghi MK.

Neurosurgery. 2018 Nov 16. doi: 10.1093/neuros/nyy501. [Epub ahead of print]

PMID:
30445646
8.

Modeling and estimating the feedback mechanisms among depression, rumination, and stressors in adolescents.

Hosseinichimeh N, Wittenborn AK, Rick J, Jalali MS, Rahmandad H.

PLoS One. 2018 Sep 27;13(9):e0204389. doi: 10.1371/journal.pone.0204389. eCollection 2018.

9.

The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.

Parker A, Knapp P, Treweek S, Madhurasinghe V, Littleford R, Gallant S, Sullivan F, Schembri S, Rick J, Graffy J, Collier DJ, Eldridge S, Kennedy A, Bower P.

Trials. 2018 Sep 18;19(1):503. doi: 10.1186/s13063-018-2896-9.

10.

Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes.

Rick J, Jahangiri A, Flanigan PM, Chandra A, Kunwar S, Blevins L, Aghi MK.

J Neurosurg. 2018 Sep 1:1-7. doi: 10.3171/2018.4.JNS18230. [Epub ahead of print]

PMID:
30215558
11.

Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials.

Rick J, Clarke M, Montgomery AA, Brocklehurst P, Evans R, Bower P.

Trials. 2018 Sep 10;19(1):481. doi: 10.1186/s13063-018-2862-6.

12.

Preinjury employment status as a risk factor for symptomatology and disability in mild traumatic brain injury: A TRACK-TBI analysis.

Yue JK, Rick JW, Morrissey MR, Taylor SR, Deng H, Suen CG, Vassar MJ, Cnossen MC, Lingsma HF, Yuh EL, Mukherjee P, Gardner RC, Valadka AB, Okonkwo DO, Cage TA, Manley GT; TRACK-TBI Investigators.

NeuroRehabilitation. 2018;43(2):169-182. doi: 10.3233/NRE-172375.

PMID:
30040754
13.

Functional brain mapping: overview of techniques and their application to neurosurgery.

Sagar S, Rick J, Chandra A, Yagnik G, Aghi MK.

Neurosurg Rev. 2019 Sep;42(3):639-647. doi: 10.1007/s10143-018-1007-4. Epub 2018 Jul 13. Review.

PMID:
30006663
14.

Disparities in health care determine prognosis in newly diagnosed glioblastoma.

Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK.

Neurosurg Focus. 2018 Jun;44(6):E16. doi: 10.3171/2018.3.FOCUS1852.

15.

Petrous Face Meningiomas: Classification, Clinical Syndromes, and Surgical Outcomes.

Magill ST, Rick JW, Chen WC, Haase DA, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW.

World Neurosurg. 2018 Jun;114:e1266-e1274. doi: 10.1016/j.wneu.2018.03.194. Epub 2018 Apr 4.

16.

Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.

Zhen A, Peterson CW, Carrillo MA, Reddy SS, Youn CS, Lam BB, Chang NY, Martin HA, Rick JW, Kim J, Neel NC, Rezek VK, Kamata M, Chen ISY, Zack JA, Kiem HP, Kitchen SG.

PLoS Pathog. 2018 Mar 12;14(3):e1006891. doi: 10.1371/journal.ppat.1006891. eCollection 2018 Mar.

17.

Collaborative case management to aid return to work after long-term sickness absence: a pilot randomised controlled trial.

Kenning C, Lovell K, Hann M, Agius R, Bee PE, Chew-Graham C, Coventry PA, van der Feltz-Cornelis CM, Gilbody S, Hardy G, Kellett S, Kessler D, McMillan D, Reeves D, Rick J, Sutton M, Bower P.

Southampton (UK): NIHR Journals Library; 2018 Jan.

18.

Tumor treating fields: a new approach to glioblastoma therapy.

Rick J, Chandra A, Aghi MK.

J Neurooncol. 2018 May;137(3):447-453. doi: 10.1007/s11060-018-2768-x. Epub 2018 Jan 18. Review.

PMID:
29349613
19.

Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.

Zhen A, Peterson CW, Carrillo MA, Reddy SS, Youn CS, Lam BB, Chang NY, Martin HA, Rick JW, Kim J, Neel NC, Rezek VK, Kamata M, Chen ISY, Zack JA, Kiem HP, Kitchen SG.

PLoS Pathog. 2017 Dec 28;13(12):e1006753. doi: 10.1371/journal.ppat.1006753. eCollection 2017 Dec. Erratum in: PLoS Pathog. 2018 Mar 12;14 (3):e1006891.

20.

Reduction of shunt dependency rates following aneurysmal subarachnoid hemorrhage by tandem fenestration of the lamina terminalis and membrane of Liliequist during microsurgical aneurysm repair.

Winkler EA, Burkhardt JK, Rutledge WC, Rick JW, Partow CP, Yue JK, Birk H, Bach AM, Raygor KP, Lawton MT.

J Neurosurg. 2018 Nov 1;129(5):1166-1172. doi: 10.3171/2017.5.JNS163271.

PMID:
29243978
21.

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS.

Mov Disord. 2018 Feb;33(2):289-297. doi: 10.1002/mds.27204. Epub 2017 Nov 23.

22.

Temporal profile of care following mild traumatic brain injury: predictors of hospital admission, follow-up referral and six-month outcome.

Yue JK, Winkler EA, Sharma S, Vassar MJ, Ratcliff JJ, Korley FK, Seabury SA, Ferguson AR, Lingsma HF, Deng H, Meeuws S, Adeoye OM, Rick JW, Robinson CK, Duarte SM, Yuh EL, Mukherjee P, Dikmen SS, McAllister TW, Diaz-Arrastia R, Valadka AB, Gordon WA, Okonkwo DO, Manley GT; the TRACK-TBI Investigators.

Brain Inj. 2017;31(13-14):1820-1829. doi: 10.1080/02699052.2017.1351000. Erratum in: Brain Inj. 2018;32(3):381.

PMID:
29166203
23.

Efficacy of decompressive craniectomy in the management of intracranial pressure in severe traumatic brain injury.

Yue JK, Rick JW, Deng H, Feldman MJ, Winkler EA.

J Neurosurg Sci. 2019 Aug;63(4):425-440. doi: 10.23736/S0390-5616.17.04133-9. Epub 2017 Nov 7.

PMID:
29115100
24.

Update on critical care for acute spinal cord injury in the setting of polytrauma.

Yue JK, Winkler EA, Rick JW, Deng H, Partow CP, Upadhyayula PS, Birk HS, Chan AK, Dhall SS.

Neurosurg Focus. 2017 Nov;43(5):E19. doi: 10.3171/2017.7.FOCUS17396. Review.

PMID:
29088951
25.

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.

Jahangiri A, Nguyen A, Chandra A, Sidorov MK, Yagnik G, Rick J, Han SW, Chen W, Flanigan PM, Schneidman-Duhovny D, Mascharak S, De Lay M, Imber B, Park CC, Matsumoto K, Lu K, Bergers G, Sali A, Weiss WA, Aghi MK.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8685-E8694. doi: 10.1073/pnas.1701821114. Epub 2017 Sep 26.

26.

Statins and Cognition in Parkinson's Disease.

Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D.

J Parkinsons Dis. 2017;7(4):661-667. doi: 10.3233/JPD-171113.

27.

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.

Akhtar RS, Xie SX, Chen YJ, Rick J, Gross RG, Nasrallah IM, Van Deerlin VM, Trojanowski JQ, Chen-Plotkin AS, Hurtig HI, Siderowf AD, Dubroff JG, Weintraub D.

PLoS One. 2017 May 25;12(5):e0177924. doi: 10.1371/journal.pone.0177924. eCollection 2017.

28.

Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Rick JW, Chang SM, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2017 Nov 1;81(5):824-833. doi: 10.1093/neuros/nyx084.

29.

Response to the 'Comment on the editorial by Turner et al. on Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.'

Rick JT, Caveney E.

Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):130. doi: 10.1093/ehjcvp/pvx011. No abstract available.

PMID:
28444393
30.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, Weintraub D.

J Parkinsons Dis. 2017;7(2):385-395. doi: 10.3233/JPD-171081.

31.

The Patient Assessment of Chronic Illness Care produces measurements along a single dimension: results from a Mokken analysis.

Gibbons CJ, Small N, Rick J, Burt J, Hann M, Bower P.

Health Qual Life Outcomes. 2017 Apr 4;15(1):61. doi: 10.1186/s12955-017-0638-4.

32.

An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial.

Cockayne S, Fairhurst C, Adamson J, Hewitt C, Hull R, Hicks K, Keenan AM, Lamb SE, Green L, McIntosh C, Menz HB, Redmond AC, Rodgers S, Torgerson DJ, Vernon W, Watson J, Knapp P, Rick J, Bower P, Eldridge S, Madurasinghe VW, Graffy J.

Trials. 2017 Mar 28;18(1):144. doi: 10.1186/s13063-017-1797-7.

33.

Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection.

Chen WC, Magill ST, Englot DJ, Baal JD, Wagle S, Rick JW, McDermott MW.

Neurosurgery. 2017 Aug 1;81(2):297-306. doi: 10.1093/neuros/nyx001.

34.

Invasion trajectory of Pacific oysters in the northern Wadden Sea.

Reise K, Buschbaum C, Büttger H, Rick J, Wegner KM.

Mar Biol. 2017;164(4):68. doi: 10.1007/s00227-017-3104-2. Epub 2017 Mar 6.

35.

Highly sensitive and stable Ag@SiO2 nanocubes for label-free SERS-photoluminescence detection of biomolecules.

Nguyen MK, Su WN, Chen CH, Rick J, Hwang BJ.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Mar 15;175:239-245. doi: 10.1016/j.saa.2016.12.024. Epub 2016 Dec 18.

PMID:
28043067
36.

Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.

Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, Carrillo M, Martin H, Kasparian S, Syed P, Rice N, Brooks DG, Kitchen SG.

J Clin Invest. 2017 Jan 3;127(1):260-268. doi: 10.1172/JCI89488. Epub 2016 Dec 12.

37.

DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury.

Yue JK, Winkler EA, Rick JW, Burke JF, McAllister TW, Oh SS, Burchard EG, Hu D, Rosand J, Temkin NR, Korley FK, Sorani MD, Ferguson AR, Lingsma HF, Sharma S, Robinson CK, Yuh EL, Tarapore PE, Wang KK, Puccio AM, Mukherjee P, Diaz-Arrastia R, Gordon WA, Valadka AB, Okonkwo DO, Manley GT; TRACK-TBI Investigators.

Neurogenetics. 2017 Jan;18(1):29-38. doi: 10.1007/s10048-016-0500-6. Epub 2016 Nov 8.

38.

Patients cured of acromegaly do not experience improvement of their skull deformities.

Rick JW, Jahangiri A, Flanigan PM, Aghi MK.

Pituitary. 2017 Apr;20(2):292-294. doi: 10.1007/s11102-016-0741-2.

PMID:
27590786
39.

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model.

Zhen A, Rezek V, Youn C, Rick J, Lam B, Chang N, Zack J, Kamata M, Kitchen S.

J Vis Exp. 2016 Jul 2;(113). doi: 10.3791/54048.

40.
41.

Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease.

Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, Kabadi S, Ruparel K, Chen-Plotkin AS, Chahine LM, Dahodwala NA, Duda JE, Weintraub DA, Moberg PJ.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1303-1310. doi: 10.1136/jnnp-2015-312723. Epub 2016 Apr 12.

42.

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.

Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D.

Parkinsonism Relat Disord. 2016 Apr;25:21-6. doi: 10.1016/j.parkreldis.2016.02.020. Epub 2016 Feb 21.

43.

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.

Berlyand Y, Weintraub D, Xie SX, Mellis IA, Doshi J, Rick J, McBride J, Davatzikos C, Shaw LM, Hurtig H, Trojanowski JQ, Chen-Plotkin AS.

PLoS One. 2016 Jan 26;11(1):e0147319. doi: 10.1371/journal.pone.0147319. eCollection 2016.

44.

Biosensors Incorporating Bimetallic Nanoparticles.

Rick J, Tsai MC, Hwang BJ.

Nanomaterials (Basel). 2015 Dec 31;6(1). pii: E5. doi: 10.3390/nano6010005. Review.

45.

Depression as a systemic syndrome: mapping the feedback loops of major depressive disorder.

Wittenborn AK, Rahmandad H, Rick J, Hosseinichimeh N.

Psychol Med. 2016 Feb;46(3):551-62. doi: 10.1017/S0033291715002044. Epub 2015 Dec 1. Review.

46.

Innovative Strategy on Hydrogen Evolution Reaction Utilizing Activated Liquid Water.

Hwang BJ, Chen HC, Mai FD, Tsai HY, Yang CP, Rick J, Liu YC.

Sci Rep. 2015 Nov 6;5:16263. doi: 10.1038/srep16263.

47.

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.

Klein S, Rick J, Lehmann J, Schierwagen R, Schierwagen IG, Verbeke L, Hittatiya K, Uschner FE, Manekeller S, Strassburg CP, Wagner KU, Sayeski PP, Wolf D, Laleman W, Sauerbruch T, Trebicka J.

Gut. 2017 Jan;66(1):145-155. doi: 10.1136/gutjnl-2015-309600. Epub 2015 Sep 17.

PMID:
26385087
48.

Longitudinal study of normal cognition in Parkinson disease.

Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D.

Neurology. 2015 Oct 13;85(15):1276-82. doi: 10.1212/WNL.0000000000002001. Epub 2015 Sep 11.

49.

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Ioannidis JP, Singleton AB; Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators.

Lancet Neurol. 2015 Oct;14(10):1002-9. doi: 10.1016/S1474-4422(15)00178-7. Epub 2015 Aug 10.

50.

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.

Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D.

Mov Disord. 2016 Jan;31(1):126-34. doi: 10.1002/mds.26339. Epub 2015 Aug 7.

Supplemental Content

Support Center